rfk tirzepatide + B6 | Boston Health Secretary Robert F. Kennedy

Virta has been prescribing GLP-1s for diabetes for nearly a decade

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a person loses while taking the GLP-1 medication, a new study finds.

GLP-1 medications show promise for adolescent weight management, but FDA approval remains limited to adults

(GLP-1)

Explore the electronic prior authorization (ePA) workflow for GLP-1 drugs

The company plans to start assessing the effects of semaglutide, the active ingredient in Ozempic, and other medicines on alcohol consumption this month in a newly announced clinical trial in alcohol-related liver disease although cutting drinking isnt the studys main goal.